Dr. Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award
Research Assistant of Tabriz university of medical sciences, Iran.
Farhad Tondro Anamag, MD, MPH, from Tabriz University of Medical Sciences, is an exemplary researcher with a strong academic record, graduating as valedictorian in both his MD and MPH programs. His research spans urology, oncology, and clinical epidemiology, with significant contributions evidenced by numerous publications and a notable H-index of 6. Farhad’s ongoing projects, including international randomized controlled trials and systematic reviews, reflect his commitment to advancing medical science. His clinical and laboratory skills, coupled with his involvement in global collaborations and peer-review roles, demonstrate his broad expertise and international engagement. Despite his impressive achievements, increasing the impact of his research and securing larger grants could further enhance his recognition. Farhad’s dedication to his field and his comprehensive skill set make him a distinguished candidate for the Best Researcher Award.
Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences.
Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service.
Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery.
Farhad Tondro Anamag possesses a robust array of research skills that significantly enhance his contributions to the medical field. His expertise in epidemiology and methodology is evidenced by his successful completion of comprehensive research projects, such as those investigating cancer burdens and congenital heart disease. Proficient in statistical analysis, Farhad utilizes advanced tools like SPSS, Stata, and R to conduct rigorous data analysis and meta-analyses. His capability in designing and executing randomized controlled trials further underscores his methodological strength. Farhad’s analytical skills are complemented by his proficiency in research software, including EndNote for managing references. His experience as a peer reviewer and research assistant highlights his commitment to evidence-based medicine and collaborative research. Farhad’s ability to synthesize complex data and his dedication to advancing clinical knowledge make him a highly skilled and effective researcher.
Awards and Recognition
Farhad Tondro Anamag has earned significant accolades and recognition throughout his academic and research career. Notably, he ranked in the top 2.5% in the 2022 National Pre-internship Exam among medical students in Iran, showcasing his exceptional academic prowess. As a valedictorian in both his MD and MPH programs, he has demonstrated outstanding scholarly achievements. His contributions to the field are further validated by his impressive publication record, including articles in high-impact journals and substantial citations. Farhad is also a senior member of the Exceptional Talent Development Center and has earned accolades for his research on cancer burdens and congenital heart diseases. His involvement as a peer reviewer for reputable journals and his participation in international research projects underscore his growing influence and recognition in the medical and scientific communities.
Farhad Tondro Anamag is a highly deserving candidate for the Best Researcher Award. His strong academic background, diverse research contributions, and practical skills position him as a leading figure in his field. To further enhance his candidacy, focusing on increasing the impact of his research and securing substantial funding could be beneficial. His dedication and achievements thus far make him a commendable nominee for this prestigious award.
Publications Top Notes
- Comparison of Cervical Length Measured by Pelvic Organ Prolapse Quantification System and Sonography
- Authors: Tondro Anamag, F., Noshad Iran, L., Mousavi, S., Salehi-Pourmehr, H., Bastani, P.
- Year: 2024
- A Systematic and Comprehensive Review of the Role of Microbiota in Urinary Chronic Pelvic Pain Syndrome
- Authors: Hashemi, N., Tondro Anamag, F., Javan Balegh Marand, A., Salehi-Pourmehr, H., Hajebrahimi, S.
- Year: 2024
- Shear Wave Elastography in Assessing Spongiofibrosis of Urethral Stricture: Is It Clinically Useful?
- Authors: Tondro Anamag, F., Sedigh, O., Tarzamni, M.K., Soleimanzadeh, F., Hosseini, J.
- Year: 2024
- Association Between Cannabis Use and Risk of Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis
- Authors: Mousavi, S.E., Tondro Anamag, F., Sanaie, S.
- Year: 2023
- Citations: 4
- Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019
- Authors: Tondro Anamag, F., Noori, M., Nejadghaderi, S.A., Kolahi, A.-A., Safiri, S.
- Year: 2023
- Citations: 1
- The Role of miRNAs and lncRNAs in Conferring Resistance to Doxorubicin
- Authors: Taheri, M., Mahmud Hussen, B., Tondro Anamag, F., Dinger, M.E., Ghafouri-Fard, S.
- Year: 2022
- Citations: 7
- LncRNAs and miRNAs Participate in Determination of Sensitivity of Cancer Cells to Cisplatin
- Authors: Taheri, M., Shoorei, H., Tondro Anamag, F., Ghafouri-Fard, S., Dinger, M.E.
- Year: 2021
- Citations: 34
- The Emerging Role of Non-Coding RNAs in the Regulation of PI3K/AKT Pathway in the Carcinogenesis Process
- Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Majidpoor, J., Taheri, M.
- Year: 2021
- Citations: 50
- 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
- Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Basiri, A., Taheri, M.
- Year: 2021
- Citations: 79